Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Tianyang Mao, Benjamin Israelow, Mario A. Peña-Hernández, et al.
Science (2022) Vol. 378, Iss. 6622
Open Access | Times Cited: 250

Showing 1-25 of 250 citing articles:

Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 175
Mucosal immune responses to infection and vaccination in the respiratory tract
Robert C. Mettelman, E. Kaitlynn Allen, Paul G. Thomas
Immunity (2022) Vol. 55, Iss. 5, pp. 749-780
Open Access | Times Cited: 155
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses
David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
Cell Host & Microbe (2023) Vol. 31, Iss. 1, pp. 146-157
Open Access | Times Cited: 132
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Yeji Lee, Michaela Jeong, Jeongeun Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2085-2096
Open Access | Times Cited: 124
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1
Qian Wang, Yicheng Guo, Anthony Bowen, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 3, pp. 315-321.e3
Open Access | Times Cited: 111
SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity
Joey Ming Er Lim, Anthony T. Tan, Nina Le Bert, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 10
Open Access | Times Cited: 104
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 96
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 94
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Felicity Liew, Shubha Talwar, Andy Cross, et al.
EBioMedicine (2022) Vol. 87, pp. 104402-104402
Open Access | Times Cited: 90
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
Alexandra Suberi, Molly K. Grun, Tianyang Mao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 709
Open Access | Times Cited: 81
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 78
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 70
Clinical delivery of circular RNA: Lessons learned from RNA drug development
Tiana L. Young, Kevin Chang Wang, Andrew Varley, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114826-114826
Closed Access | Times Cited: 69
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Geraldine Nouailles, Julia M. Adler, Peter Pennitz, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 860-874
Open Access | Times Cited: 64
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 48
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
Qianqian Huang, Yongke Chen, Weiwei Zhang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 519-534
Closed Access | Times Cited: 44
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants
Qian Wang, Yicheng Guo, Anthony Bowen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 43
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 21
Exploring new perspectives in immunology
Ruslan Medzhitov, Akiko Iwasaki
Cell (2024) Vol. 187, Iss. 9, pp. 2079-2094
Open Access | Times Cited: 19
Vaccine adjuvants: Tailoring innate recognition to send the right message
Ed C. Lavelle, Craig P. McEntee
Immunity (2024) Vol. 57, Iss. 4, pp. 772-789
Open Access | Times Cited: 18
Amphiphilic Block Copolymer Nanostructures as a Tunable Delivery Platform: Perspective and Framework for the Future Drug Product Development
Gaurav Sinsinbar, Anivind Kaur Bindra, Shaoqiong Liu, et al.
Biomacromolecules (2024) Vol. 25, Iss. 2, pp. 541-563
Closed Access | Times Cited: 16
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
Baoling Ying, Tamarand L. Darling, Pritesh Desai, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 537-551
Open Access | Times Cited: 16
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 2
Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
Evropi Amanatidou, Anna Gkiouliava, Eva Pella, et al.
Metabolism Open (2022) Vol. 14, pp. 100180-100180
Open Access | Times Cited: 68
Page 1 - Next Page

Scroll to top